Life Sciences Industry Accounting Guide — March 2024
The 2024 edition of this guide addresses topics of relevance to finance and accounting professionals in the life sciences industry, including acquisitions and divestitures, consolidation, contingencies and loss recoveries, financial instruments, income taxes, leases, research and development, and revenue recognition. In addition to providing interpretive guidance and illustrative examples, the guide discusses (1) recent standard-setting and rulemaking developments (through March 8, 2024); (2) SEC comment letter themes; (3) key differences between U.S. GAAP and IFRS® Accounting Standards; (4) accounting and reporting considerations related to the current macroeconomic and geopolitical environment; (5) environmental, social, and governance matters; and (6) the impact of the Inflation Reduction Act of 2022.
